XML 55 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information (Tables)
12 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
The following table presents revenue for each reportable segment and Corporate:
(in millions)
2020
 
2019
 
2018
Pharmaceutical
$
137,495

 
$
129,917

 
$
121,241

Medical
15,444

 
15,633

 
15,581

Total segment revenue
152,939

 
145,550

 
136,822

Corporate (1)
(17
)
 
(16
)
 
(13
)
Total revenue
$
152,922

 
$
145,534

 
$
136,809

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue by Reportable Segment
The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:
(in millions)
2020
2019
Pharmaceutical Distribution and Specialty Solutions (1) (2)
$
136,693

$
129,067

Nuclear and Precision Health Solutions
802

850

Pharmaceutical segment revenue
137,495

129,917

Medical distribution and products (3)
13,429

13,833

Cardinal Health at-Home Solutions
2,015

1,800

Medical segment revenue
15,444

15,633

  Total segment revenue
152,939

145,550

Corporate (4)
(17
)
(16
)
Total revenue
$
152,922

$
145,534


(1)
Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services"
(2)
Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.
(3)
Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division
(4)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Disaggregation of Revenue [Table Text Block]
(in millions)
2020
2019
Pharmaceutical Distribution and Specialty Solutions (1) (2)
$
136,693

$
129,067

Nuclear and Precision Health Solutions
802

850

Pharmaceutical segment revenue
137,495

129,917

Medical distribution and products (3)
13,429

13,833

Cardinal Health at-Home Solutions
2,015

1,800

Medical segment revenue
15,444

15,633

  Total segment revenue
152,939

145,550

Corporate (4)
(17
)
(16
)
Total revenue
$
152,922

$
145,534


(1)
Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services"
(2)
Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.
(3)
Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division
(4)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following table presents revenue by geographic area:
(in millions)
2020
 
2019
 
2018
United States
$
148,707

 
$
141,479

 
$
132,539

International
4,232

 
4,071

 
4,283

Total segment revenue
152,939

 
145,550

 
136,822

Corporate (1)
(17
)
 
(16
)
 
(13
)
Total revenue
$
152,922

 
$
145,534

 
$
136,809

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present segment profit by reportable segment and Corporate:
(in millions)
2020
 
2019
 
2018
Pharmaceutical
$
1,753

 
$
1,834

 
$
1,992

Medical
663

 
576

 
662

Total segment profit
2,416

 
2,410

 
2,654

Corporate
(6,514
)
 
(350
)
 
(2,528
)
Total operating earnings
$
(4,098
)
 
$
2,060

 
$
126


Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment
The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:
(in millions)
2020
 
2019
 
2018
Pharmaceutical
$
135

 
$
147

 
$
156

Medical
243

 
288

 
278

Corporate
535

 
565

 
598

Total depreciation and amortization
$
913

 
$
1,000

 
$
1,032

(in millions)
2020
 
2019
 
2018
Pharmaceutical
$
47

 
$
35

 
$
58

Medical
86

 
74

 
127

Corporate
242

 
219

 
199

Total additions to property and equipment
$
375

 
$
328

 
$
384


Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at June 30:
(in millions)
2020
 
2019
 
2018
Pharmaceutical
$
22,398

 
$
22,446

 
$
21,421

Medical
14,691

 
15,284

 
16,066

Corporate
3,677

 
3,233

 
2,464

Total assets
$
40,766

 
$
40,963

 
$
39,951


Property and Equipment, Net by Geographic Area
The following tables present property and equipment, net by geographic area:
(in millions)
2020
 
2019
 
2018
United States
$
1,880

 
$
1,846

 
$
1,950

International
486

 
510

 
537

Property and equipment, net
$
2,366

 
$
2,356

 
$
2,487